{"id":"https://openalex.org/W4416219418","doi":"https://doi.org/10.1136/heartjnl-2025-bcs.212","title":"7-016 Efficacy of Inclisiran in patients post myocardial infarction with high total cholesterol and LDL levels and intolerance to statins","display_name":"7-016 Efficacy of Inclisiran in patients post myocardial infarction with high total cholesterol and LDL levels and intolerance to statins","publication_year":2025,"publication_date":"2025-08-13","ids":{"openalex":"https://openalex.org/W4416219418","doi":"https://doi.org/10.1136/heartjnl-2025-bcs.212"},"language":"en","primary_location":{"id":"doi:10.1136/heartjnl-2025-bcs.212","doi":"https://doi.org/10.1136/heartjnl-2025-bcs.212","is_oa":true,"landing_page_url":"https://doi.org/10.1136/heartjnl-2025-bcs.212","pdf_url":"https://heart.bmj.com/content/heartjnl/111/Suppl_3/A216.full.pdf","source":{"id":"https://openalex.org/S191565391","display_name":"Heart","issn_l":"1355-6037","issn":["1355-6037","1468-201X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Stable IHD/Prevention/Hypertension/Lipids","raw_type":"proceedings-article"},"volume":null,"type":"conference-paper","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://heart.bmj.com/content/heartjnl/111/Suppl_3/A216.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042006002","display_name":"Yi Lung Gan","orcid":"https://orcid.org/0000-0002-7791-5212","observed_orcids":["https://orcid.org/0000-0002-7791-5212"]},"institutions":[{"id":"https://openalex.org/I4210135561","display_name":"Walsall Manor Hospital","ror":"https://ror.org/04bmgpj29","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210135561","https://openalex.org/I4210147609"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Yi Lung Gan","raw_affiliation_strings":["Cardiology Unit, Department of Medicine, Manor Hospital, Walsall, WS2 9PS, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiology Unit, Department of Medicine, Manor Hospital, Walsall, WS2 9PS, UK","institution_ids":["https://openalex.org/I4210135561"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043095640","display_name":"Anura Kalansooriya","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210135561","display_name":"Walsall Manor Hospital","ror":"https://ror.org/04bmgpj29","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210135561","https://openalex.org/I4210147609"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Anura Kalansooriya","raw_affiliation_strings":["Cardiology Unit, Department of Medicine, Manor Hospital, Walsall, WS2 9PS, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiology Unit, Department of Medicine, Manor Hospital, Walsall, WS2 9PS, UK","institution_ids":["https://openalex.org/I4210135561"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111212941","display_name":"Hannah Tranter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210135561","display_name":"Walsall Manor Hospital","ror":"https://ror.org/04bmgpj29","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210135561","https://openalex.org/I4210147609"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Hannah Tranter","raw_affiliation_strings":["Cardiology Unit, Department of Medicine, Manor Hospital, Walsall, WS2 9PS, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiology Unit, Department of Medicine, Manor Hospital, Walsall, WS2 9PS, UK","institution_ids":["https://openalex.org/I4210135561"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111212942","display_name":"Hana Jaumdally","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Hana Jaumdally","raw_affiliation_strings":["Medical School of King`s, Guy`s and St Thomas`, Strand, London WC2R 2LS UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical School of King`s, Guy`s and St Thomas`, Strand, London WC2R 2LS UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076994455","display_name":"Andrew J. Hartland","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210135561","display_name":"Walsall Manor Hospital","ror":"https://ror.org/04bmgpj29","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210135561","https://openalex.org/I4210147609"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Andrew Hartland","raw_affiliation_strings":["Cardiology Unit, Department of Medicine, Manor Hospital, Walsall, WS2 9PS, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiology Unit, Department of Medicine, Manor Hospital, Walsall, WS2 9PS, UK","institution_ids":["https://openalex.org/I4210135561"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069510779","display_name":"Rumi J. Jaumdally","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210135561","display_name":"Walsall Manor Hospital","ror":"https://ror.org/04bmgpj29","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210135561","https://openalex.org/I4210147609"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rumi Jaumdally","raw_affiliation_strings":["Cardiology Unit, Department of Medicine, Manor Hospital, Walsall, WS2 9PS, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiology Unit, Department of Medicine, Manor Hospital, Walsall, WS2 9PS, UK","institution_ids":["https://openalex.org/I4210135561"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A216","last_page":"A217"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10292","display_name":"Acute Myocardial Infarction Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/inclisiran","display_name":"inclisiran","score":0.8610000014305115},{"id":"https://openalex.org/keywords/pcsk9-inhibition","display_name":"PCSK9 inhibition","score":0.8510000109672546},{"id":"https://openalex.org/keywords/rna-interference","display_name":"RNA interference","score":0.7289999723434448},{"id":"https://openalex.org/keywords/statin-intolerance","display_name":"statin intolerance","score":0.8220000267028809},{"id":"https://openalex.org/keywords/myocardial-infarction","display_name":"myocardial infarction","score":0.8970000147819519},{"id":"https://openalex.org/keywords/hypercholesterolemia","display_name":"hypercholesterolemia","score":0.8790000081062317},{"id":"https://openalex.org/keywords/ldl-cholesterol-lowering","display_name":"LDL cholesterol lowering","score":0.847000002861023},{"id":"https://openalex.org/keywords/total-cholesterol-reduction","display_name":"total cholesterol reduction","score":0.8500000238418579},{"id":"https://openalex.org/keywords/lipid-lowering-therapy","display_name":"lipid-lowering therapy","score":0.824999988079071},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.5640000104904175},{"id":"https://openalex.org/keywords/real-world-effectiveness","display_name":"real-world effectiveness","score":0.6669999957084656},{"id":"https://openalex.org/keywords/nice-guidance","display_name":"NICE guidelines","score":0.4399999976158142},{"id":"https://openalex.org/keywords/secondary-prevention","display_name":"secondary prevention","score":0.36500000953674316},{"id":"https://openalex.org/keywords/lipid-lowering-drugs","display_name":"lipid-lowering drugs","score":0.34200000762939453},{"id":"https://openalex.org/keywords/ezetimibe","display_name":"ezetimibe","score":0.8429999947547913},{"id":"https://openalex.org/keywords/pcsk9-inhibitors","display_name":"PCSK9 inhibitors","score":0.5839999914169312}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8797000050544739},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.629800021648407},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5787000060081482},{"id":"https://openalex.org/C2778270857","wikidata":"https://www.wikidata.org/wiki/Q2723972","display_name":"Lipid profile","level":3,"score":0.5127000212669373},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.5027999877929688},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.4884999990463257},{"id":"https://openalex.org/C2994423189","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Total cholesterol","level":3,"score":0.4765999913215637},{"id":"https://openalex.org/C3019550498","wikidata":"https://www.wikidata.org/wiki/Q28749","display_name":"Ldl cholesterol","level":3,"score":0.4462999999523163},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.4106000065803528},{"id":"https://openalex.org/C2779519902","wikidata":"https://www.wikidata.org/wiki/Q1240093","display_name":"Pravastatin","level":3,"score":0.38339999318122864},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.34299999475479126},{"id":"https://openalex.org/C2777320049","wikidata":"https://www.wikidata.org/wiki/Q2989497","display_name":"Hydroxymethylglutaryl-CoA reductase","level":5,"score":0.32710000872612},{"id":"https://openalex.org/C2778096610","wikidata":"https://www.wikidata.org/wiki/Q1476525","display_name":"Dyslipidemia","level":3,"score":0.3100000023841858},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.30379998683929443},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.3034000098705292},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.29989999532699585},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2955000102519989},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.28600001335144043},{"id":"https://openalex.org/C2779091943","wikidata":"https://www.wikidata.org/wiki/Q1079120","display_name":"Hyperlipidemia","level":3,"score":0.2728999853134155},{"id":"https://openalex.org/C2777798775","wikidata":"https://www.wikidata.org/wiki/Q207550","display_name":"Infarction","level":3,"score":0.26510000228881836},{"id":"https://openalex.org/C139572402","wikidata":"https://www.wikidata.org/wiki/Q4927820","display_name":"Blood lipids","level":3,"score":0.25529998540878296}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/heartjnl-2025-bcs.212","doi":"https://doi.org/10.1136/heartjnl-2025-bcs.212","is_oa":true,"landing_page_url":"https://doi.org/10.1136/heartjnl-2025-bcs.212","pdf_url":"https://heart.bmj.com/content/heartjnl/111/Suppl_3/A216.full.pdf","source":{"id":"https://openalex.org/S191565391","display_name":"Heart","issn_l":"1355-6037","issn":["1355-6037","1468-201X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Stable IHD/Prevention/Hypertension/Lipids","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/heartjnl-2025-bcs.212","doi":"https://doi.org/10.1136/heartjnl-2025-bcs.212","is_oa":true,"landing_page_url":"https://doi.org/10.1136/heartjnl-2025-bcs.212","pdf_url":"https://heart.bmj.com/content/heartjnl/111/Suppl_3/A216.full.pdf","source":{"id":"https://openalex.org/S191565391","display_name":"Heart","issn_l":"1355-6037","issn":["1355-6037","1468-201X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Stable IHD/Prevention/Hypertension/Lipids","raw_type":"proceedings-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4416219418.pdf","grobid_xml":"https://content.openalex.org/works/W4416219418.grobid-xml"},"referenced_works_count":1,"referenced_works":["https://openalex.org/W3183857127"],"related_works":["https://openalex.org/W7203491025","https://openalex.org/W4377019136","https://openalex.org/W7168928262","https://openalex.org/W4403153654","https://openalex.org/W4412419097","https://openalex.org/W7138946658","https://openalex.org/W7211990249","https://openalex.org/W4306320554","https://openalex.org/W2595169180","https://openalex.org/W4415790031"],"abstract_inverted_index":{"Introduction":[0],"Inclisiran":[1,27,66,79,303,416,449,513,566],"is":[2,93,124],"an":[3,125,158,225,249,373,383,394,431],"RNA":[4],"interfering":[5],"drug":[6],"which":[7,129],"binds":[8],"to":[9,44,56,61,76,83,149,267,305,344,415,451,476,480,488,602],"the":[10,13,63,91,130,135,168,235,325,548,553,596,606,610,615],"mRNA":[11],"of":[12,32,65,86,173,197,228,252,261,274,283,299,302,310,319,377,387,398,405,428,448,485,507,533,552,563,598,612,614,618],"precursor":[14],"for":[15,180,202,208,421,567,595,609],"proprotein":[16],"convertase":[17],"subtilisin-kexin":[18],"type":[19],"9":[20,362],"(PCSK9).":[21],"Recent":[22],"trials1\u20133":[23],"have":[24],"showed":[25,372],"that":[26,498],"resulted":[28],"in":[29,42,290,455,460,490,535],"a":[30,269,306,452,482,499,505],"reduction":[31,215,227,239,251,273,282,309,318,376,386,397,454],"LDL-cholesterol":[33],"(LDL-C)":[34],"by":[35],"about":[36],"47%,":[37],"sustained":[38],"over":[39],"4":[40],"years":[41],"addition":[43],"maximum":[45,100],"tolerated":[46,101,120],"statins":[47,102,117,264,293],"or":[48,104,110,121,355,509,571],"other":[49,106,112,356],"lipid":[50,107,113,160,600],"lowering":[51,108,114],"therapy.":[52],"This":[53,123],"study":[54,128,496],"aims":[55],"utilize":[57],"real":[58],"world":[59],"data":[60,131,169],"assess":[62],"efficacy":[64,530],"on":[67,99,111,190,263,511],"high-risk":[68],"patients":[69,199,207,260,327,406,429,461,493,536],"post":[70],"myocardial":[71,333,339,472],"infarction":[72,334,340,473],"and":[73,98,143,152,175,178,183,205,265,279,294,315,329,347,365,392,411,437,458,465,474,531,541,621],"those":[74,262,291,297,469],"intolerant":[75,266,298],"statins.":[77],"Method":[78],"was":[80,219,243,288],"prescribed":[81],"according":[82],"National":[84,561],"Institute":[85,562],"Clinical":[87,564],"Excellence":[88,565],"guidance2":[89],"if":[90],"LDL-C":[92,144,237,280,316,375,385,396,408,432,459],"persistently":[94],"above":[95],"2.6":[96],"mmol/l":[97,177,230,254,413,436],"with":[103,224,248,292,407,470,537],"without":[105,157],"therapy":[109],"therapies":[115],"where":[116],"are":[118],"not":[119,503],"contraindicated.":[122],"observational":[126],"prospective":[127],"were":[132,146,165,188,200,360,363,367,417],"collected":[133],"from":[134,167,547],"hospital\u2019s":[136],"electronic":[137],"system.":[138],"The":[139,171,210,369,403],"total":[140,195,203,212,456],"cholesterol":[141,204,213,457,544],"(TC)":[142],"levels":[145],"measured":[147],"prior":[148,414],"first":[150],"injection":[151],"at":[153,162,216,240,462],"day":[154,163,217,241],"90.":[155],"Patients":[156],"extended":[159],"profile":[161],"90":[164,218,242,445],"omitted":[166],"analysis.":[170],"cutoffs":[172],"1.4":[174,410,441,508],"1.8":[176,412,435],"criteria":[179],"very":[181,463],"high":[182,184,464,466,538],"cardiovascular":[185,348,539,604],"disease":[186,349],"risks":[187,350],"based":[189],"ESC":[191],"guidance.3":[192],"Results":[193],"A":[194],"number":[196],"75":[198],"included":[201],"51":[206],"LDL-C.":[209],"mean":[211,236,270,307],"percentage":[214,238,272,281,317],"28%":[220],"\u00b13":[221],"(95%":[222,232,246,256,277,286,313,322,380,390,401],"CI)":[223,233,247,278,287,314,391],"absolute":[226,250,374,384,395],"1.7":[229],"\u00b10.3":[231],"while":[234],"45%":[244,426,489],"\u00b16":[245,276,321],"1.5":[253],"\u00b10.2":[255],"CI).":[257,323,402],"In":[258,468],"subgroup":[259],"statins,":[268,300,477],"TC":[271,308],"30%":[275],"52%":[284],"\u00b112":[285],"found":[289],"Inclisiran.":[295],"For":[296],"use":[301,447],"led":[304,450],"27%":[311,438],"\u00b14":[312],"43%":[320],"Of":[324],"45":[326],"identified":[328],"grouped":[330],"into":[331],"acute":[332],"(AMI)":[335],"(<3":[336],"months),":[337],"recent":[338,471],"(RMI)":[341],"(within":[342],"3":[343],"12":[345],"months)":[346],"(CVD)":[351],"(MI":[352],">12":[353],"months":[354],"CVD":[357,393,492],"risks).":[358],"2":[359],"AMI,":[361],"RMI":[364,382],"34":[366],"CVD.":[368],"AMI":[370],"group":[371],"66%":[378,486],"\u00b140":[379],"CI),":[381],"50%":[388],"\u00b111":[389],"44%":[399],"\u00b17":[400],"numbers":[404],"below":[409,434,440],"only":[418],"2%":[419],"(1/51)":[420],"both.":[422],"On":[423],"Day":[424],"90,":[425],"(23/51)":[427],"achieved":[430],"level":[433],"(14/51)":[439],"mmol/l.":[442],"Conclusion":[443],"At":[444],"days,":[446],"significant":[453,483,500],"risk.":[467],"intolerance":[475],"there":[478],"appear":[479],"be":[481],"drop":[484],"compared":[487],"stable":[491],".":[494],"Our":[495],"indicated":[497],"proportion":[501],"did":[502],"reach":[504],"target":[506],"1.8mmol/l":[510],"singular":[512],"use.":[514],"References":[515],"Ray":[516],"KK,":[517],"Troquay":[518],"RPT,":[519],"Visseren":[520],"FLJ,":[521],"Leiter":[522],"LA,":[523],"Scott":[524],"Wright":[525],"R,":[526],"et":[527,590],"al.":[528,591],"Long-term":[529],"safety":[532],"inclisiran":[534],"risk":[540],"elevated":[542],"LDL":[543],"(ORION-3):":[545],"results":[546],"4-year":[549],"open-label":[550],"extension":[551],"ORION-1":[554],"trial.":[555],"Lancet":[556],"Diabetes":[557],"Endocrinol.":[558],"2023":[559],"Feb;11(2):109\u2013119.":[560],"treating":[568],"primary":[569],"hypercholesterolaemia":[570],"mixed":[572],"dyslipidaemia,":[573],"Technology":[574],"appraisal":[575],"guidance,":[576],"Reference":[577],"number:":[578],"TA733,":[579],"published:":[580],"06":[581],"October":[582],"2021.":[583],"Mach":[584],"F,":[585],"Baigent":[586],"C,":[587],"Catapano":[588],"AL,":[589],"2019":[592],"ESC/EAS":[593],"Guidelines":[594],"management":[597,611],"dyslipidaemias:":[599],"modification":[601],"reduce":[603],"risk:":[605],"task":[607],"force":[608],"dyslipidaemias":[613],"European":[616,622],"society":[617,624],"cardiology":[619],"(ESC)":[620],"atherosclerosis":[623],"(EAS).":[625],"Eur":[626],"Heart":[627],"J.":[628],"2020,41:111\u2013188.":[629],"doi:":[630],"10.1093/eurheartj/ehz455.":[631]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2025-10-19T00:00:00"}